MAIA Biotechnology, Inc. (MAIA) Raises $695K in Private Placement to Advance Cancer Trial
MAIA Biotechnology, Inc. (NYSE:MAIA), a clinical-stage biopharmaceutical company, has announced a private placement agreement to raise approximately $695,000.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Marshall Wace LLP Paul Marshall And Ian Wace | 110,467 | $170,119 | +584% | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.22 | 57,189 | $69,999.34 | 1,421,478 | 2025-12-22 | Filing | |
| $1.22 | 40,849 | $49,999.18 | 151,873 | 2025-12-22 | Filing | |
| $1.22 | 81,699 | $99,999.58 | 1,248,888 | 2025-12-22 | Filing | |
| $1.20 | 4,580 | $5,496.00 | 4,580 | 2025-12-05 | Filing | |
| $1.19 | 4,580 | $5,450.20 | 4,580 | 2025-12-05 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,103,145 | $1,698,844 | 0% | |
| 2. | 574,898 | $712,874 | 0.16% | |
| 3. | 271,056 | $417,526 | 0% | |
| 4. | 104,857 | $161,479 | 0% | |
| 5. | 75,550 | $116,347 | 0% |